Results: 10
Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 309, doi. 10.1007/s40264-023-01276-6
- By:
- Publication type:
- Article
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 319, doi. 10.1007/s40264-023-01275-7
- By:
- Publication type:
- Article
Correction to: Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 297, doi. 10.1007/s40264-022-01271-3
- By:
- Publication type:
- Article
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 243, doi. 10.1007/s40264-022-01270-4
- By:
- Publication type:
- Article
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 283, doi. 10.1007/s40264-022-01269-x
- By:
- Publication type:
- Article
Correction: Compliance with Prescribing and Dispensing Conditions for Valproate and Related Substances in Girls and Women of Childbearing Potential: A Survey of Community Pharmacists in France.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 257, doi. 10.1007/s40264-022-01267-z
- By:
- Publication type:
- Article
Effect of Previous Anticoagulant Treatment on Risk of COVID-19.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 273, doi. 10.1007/s40264-022-01266-0
- By:
- Publication type:
- Article
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 223, doi. 10.1007/s40264-022-01265-1
- By:
- Publication type:
- Article